Basilar artery rethrombosis: Successful treatment with platelet glycoprotein IIB/IIIA receptor inhibitor

American Journal of Neuroradiology

Volumn 18, Issue 7, 1997, Pages 1257-1260

  Wallace, Robert C ^a   Furlan, Anthony J ^a   Moliterno, David J ^a   Stevens, Glen H J ^a   Masaryk, Thomas J ^a   Perl II, John ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Arterial; Arteries; Thrombosis; Transluminal angioplasty

Indexed keywords

ABCIXIMAB; FIBRINOGEN RECEPTOR ANTAGONIST;

ADULT; ANTICOAGULATION; BASILAR ARTERY; CASE REPORT; CONFERENCE PAPER; DRUG USE; HUMAN; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; REVASCULARIZATION; THROMBOSIS; VERTEBRAL ARTERY;

ANGIOPLASTY, BALLOON; ANTIBODIES, MONOCLONAL; BASILAR ARTERY; CEREBRAL ANGIOGRAPHY; COMBINED MODALITY THERAPY; FOLLOW-UP STUDIES; HEPARIN; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; INTRACRANIAL EMBOLISM AND THROMBOSIS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; RECURRENCE; RETREATMENT; THROMBOLYTIC THERAPY; URINARY PLASMINOGEN ACTIVATOR;

EID: 0031545897     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (14)

1. Hacke W, Zeumer H, Ferbert A, Bruckmann H, del Zoppo GJ. Intra-arterial thrombolytic therapy improves outcome in patients with acute vertebrobasilar occlusive disease. Stroke 1988;19: 1216-1222
2. Zeumer H, Freitag HJ, Zanella F, Thie A, Arning C. Local intraarterial fibrinolytic therapy in patients with stroke: urokinase versus recombinant tissue plasminogen activator. Neuroradiology 1993;35:159-162
3. Becker KJ, Monsein LH, Mirski M, Williams M, Hanley DF. Intraarterial thrombolysis in vertebrobasilar occlusion. AJNR Am J Neuroradiol 1996;17:255-262
4. McKenzie JD, Wallace RC, Dean BL, Flom RA, Khayata MH. Preliminary results of intracranial angioplasty for vascular stenosis caused by atherosclerosis and vasculitis. AJNR Am J Neuroradiol 1996;17:263-268
5. Higashida RT, Tsai FY, Halbach VV, et al. Transluminal angioplasty for atherosclerotic disease of the vertebral and basilar arteries. J Neurosurg 1993;78:192-198
6. The EPIC Investigators. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med 1994;330:956-961
7. Shomig A, Neumann F-J, Kastrati A, et al. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Engl J Med 1996;334:1084-1089
8. Adams RJ, Nichols FT, Hess DC. Normal values and physiological variables. In: Newell DW, Aaslid R, eds. Transcranial Doppler. New York, NY: Raven Press; 1992:41-48
9. Coller BS. Blockade of platelet GPIIb/IIIa receptors as an antithrombotic strategy. Circulation 1995;92:2373-2380
10. Lefkovits J, Plow EF, Topol EJ. Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine. N Engl J Med 1995;332: 1553-1559
11. Aguirre F, Ferguson JJ, Califf, et al. Clinical predictors of bleeding complications in high risk angioplasty: results from the EPIC study group. Circulation 1993;90:I-252
12. Higashida RT, Halbach VV, Tsai FY, Dowd CF, Hieshima GB. Interventional neurovascular techniques in acute thrombolytic therapy for stroke. In: Yamaguchi T, Mori E, Minematsu K, del Zoppo GJ, eds. Thrombolytic Therapy in Acute Ischemic Stroke, III. Tokyo, Japan: Springer-Verlag; 1995;99:294-300
13. Hacke W, Kaste M, Fieschi C, for the ECASS Study Group. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. JAMA 1995;274:1017-1026
14. del Zoppo GJ, Higashida RT, Furlan AJ, et al. The prolyse in acute cerebral thromboembolism trial (PROACT): results of the 6 mg dose tier. Stroke 1996;27:164